HCP Promotions

Most visited topics:
ADA Product Theater Video   >

This 8-minute video is designed to highlight key takeaways from the Corcept Product Theater at the 2023 ADA in San

ADA Video Brochure   >

Video brochure containing both a full and chapterized version of the 2023 ADA Product Theater Video, as well as a

ADA Video Postcard   >

Leave behind postcard with a QR code to drive traffic to the ADA Product Theater Video. FIELD USE: PRINT: Discuss

Adrenal Incidentaloma Biochemical Evaluation Leave Behind   >

One page leave behind outlining the importance of a biochemical evaluation for Adrenal Incidentalomas. Includes how to administer a DST

Aresta Reprint Carrier   >

Provides important key prevalence and risk take aways available in DSE-00932 JUN 2022, the Aresta Reprint “When to Suspect Hidden

Beyond Benign: The Role of Radiologist KAM Leave Behind   >

KAM Use Only: Highlight to Radiologists the importance of evaluating adrenal incidentalomas for hormonal secretions and the importance of referring

Breaking Through Difficult-to-Control T2D: Targeting Hypercortisolism   >

Reprint of article published in The Journal of Family Practice in October 2025. Authors: Pamela Kushner and John Anderson FIELD

Brown Case Study Video   >

This is a video recording of Dr. Brown presenting his patient case study and sharing his clinical perspectives on Korlym

CATALYST Flashcard   >

The CATALYST Flashcard is intended to be discussed and is a leave behind for HCPs to showcase the prevalence data

No more resources
HCP Korlym CATALYST Reprint Carrier
US-KOR-26-0012 01-26
The US-KOR-26-0012 01-26 HCP Korlym CATALYST Reprint Carrier is designed to house the DeFronzo 2025 "Inadequately controlled type 2 diabetes and hypercortisolism: improved glycemia with mifepristone treatment" Reprint.

This material must always be distributed with US-KOR-26-0009 01-26 Diabetes Care Reprint CATALYST Part 2-Treatment with Mifepristone in the pocket with K-00014 SEPT 2024 Korlym Prescribing Information and Medication Guide. US-KOR-26-0012 and US-KOR-26-0009 must always be distributed together.

FIELD USE: 
This material must always be distributed with US-KOR-26-0009 01-26 Diabetes Care Reprint CATALYST Part 2-Treatment with Mifepristone in the pocket of this material with K-00014 SEPT 2024 Korlym Prescribing Information and Medication Guide. US-KOR-26-0012 and US-KOR-26-0009 must always be distributed together.

  • DIGITAL: May not be shared digitally
  • MAIL: Can not be mailed to HCP office.
Copy Resource Link
Visit Resource Page